Publications by authors named "Anamitro Banerjee"

Claim this Profile
F
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.
Donna Przepiorka, Robert Q Le, Alexei Ionan, Ruo-Jing Li, Ying-Hong Wang, Anamitro Banerjee

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, Laura L Fernandes, Emily Li, Anamitro Banerjee

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia.
Aviva C Krauss, Xin Gao, Liang Li, Michael L Manning, Paresma Patel, Anamitro Banerjee

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy.
Gwynn Ison, Lynn J Howie, Laleh Amiri-Kordestani, Lijun Zhang, Shenghui Tang, Anamitro Banerjee

Clin Cancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious Mutation-Associated Advanced Ovarian Cancer.
Sanjeeve Balasubramaniam, Julia A Beaver, Sara Horton, Laura L Fernandes, Shenghui Tang, Anamitro Banerjee

Clin Cancer Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A convenient synthesis of symmetric 1,2-diarylethenes from arylmethyl phosphonium salts.
Julius N Ngwendson, Walters N Atemnkeng, Cassandra M Schultze, Anamitro Banerjee

Org Lett· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photochemistry of 2-nitrobenzyl enol ethers: oxidative C=C bond scission.
Promise K Yong, Anamitro Banerjee

Org Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism-based discovery of small molecules that prevent noncompetitive inhibition by cocaine and MK-801 mediated by two different sites on the nicotinic acetylcholine receptor.
Yongli Chen, Anamitro Banerjee, George P Hess

Biochemistry· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-[2-(2-hydroxyalkyl)phenyl]ethanone: a new photoremovable protecting group for carboxylic acids.
Walters N Atemnkeng, Larry D Louisiana II, Promise K Yong, Breanne Vottero, Anamitro Banerjee

Org Lett· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the development of new photolabile protecting groups that can rapidly release bioactive compounds upon photolysis with visible light.
Anamitro Banerjee, Christof Grewer, Latha Ramakrishnan, Jürgen Jäger, Armanda Gameiro

J Org Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis